| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |